echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > October 22-23, Beijing U-Town Crown, P4 China 2021 International Oncology Precision Medicine Conference

    October 22-23, Beijing U-Town Crown, P4 China 2021 International Oncology Precision Medicine Conference

    • Last Update: 2021-08-27
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Forum official website: style="vertical-align: inherit;">On October 22-23, 2021, hosted by the Chinese Society of Bioengineering and Shanghai Shangtu Information BIOMAP, and supported by the Precision Medicine Professional Committee of the Chinese Society of Bioengineering and the In Vitro Diagnosis (IVD) Branch of the China Medical Device Industry Association, P4 China 2021 Fifth The International Oncology Precision Medicine Conference will be held at the U-Town Crown Hotel in Chaoyang District, Beijing


    More than 50 heavy guests, including academician authority / clinical examination center / supervision of the China National Supervision Institute / tumor clinical / leading diagnostic industry / precision pharmaceutical company experts, attended the meeting, focusing on the precise diagnosis and treatment of tumors, from prevention to diagnosis to treatment, from early screening , Staging and typing, prognostic testing, companion diagnostics, biomarkers, precision immune/targeted drug development and transformation, etc.


    Participants:

    In vitro diagnostics regulatory agencies (Health Commission / National Food and Drug Administration / China National Inspection Institute, etc.


    Technical innovation and application of early tumor screening/assisted early diagnosis/typing/prognosis at venue A

    DAY1 ( 10 Yue 22 days)

    DAY2 ( 10 Yue 23 days)

    Interpretation of the latest compliance policies and clinical recommendations for application and registration

    Follow up with the latest application of single cell /RNA sequencing screening technology

    Follow up the development prospects and market opportunities of tumor screening and diagnosis

    Analyze MRD/MSI and other testing and product development evaluation

    Learning and innovation, early screening of markers / methods, forward-looking research and other frontier developments

    Explore the detection of tumor types / prognosis and other markers and technological innovation

    Listen to the innovative technology of liquid biopsy for early tumor screening / assisted diagnosis

    Learn multi-omics / immunomics / new detection techniques such as mass spectrometry

    Listen to the innovative technology of liquid biopsy for early tumor screening / assisted diagnosis

    Learn multi-omics / immunomics / new detection techniques such as mass spectrometry

    [A first look at some of the exciting topics in Venue A]

    • Under the latest medical device supervision regulations: Interpretation of LDT compliance


    .


    Venue A has confirmed guests (the guest lineup is being updated continuously)

    Li Jinming, Researcher



    DAY1 ( 10 Yue 22 days)

    DAY2 ( 10 Yue 23 days)

    Explore the development of immune / targeted drugs under the guidance of biomarkers

    Study companion diagnostic testing standards / product development and drug transformation

    Learn the latest immunotherapy / immune combination and research progress of markers

    Unlock the precise clinical and transformation of drugs in the companion diagnostic mode

    Analyze pathway / target research to accelerate targeted drug conversion

    Analyze the development of biomarkers and cell therapy / combination and double antibody development

    Explore the precise clinical development and transformation of drugs under the guidance of biomarkers

    Digging deep into genetic testing and hyper-personalized immunotherapy drug development

    Special Session of the Precision Medicine Committee of the Chinese Society of Bioengineering

    Yao Shukun, Former Vice President of China-Japan Friendship Hospital, Chairman of the Precision Medicine Committee of the


    [First look at some exciting topics in venue B]

    • New progress in the research of new tumor immunotherapy drugs


    .


    More confirmed guests at venue B (the guest lineup is being continuously updated)


    Now four people sign up and enjoy a 25% discount on group purchase.


    [More] welfare concessions


    For details, please check the official website link: https:// style="vertical-align: inherit;">Participating in P4 China 2021 & IGC 2021 at the same time from now on


    For details, please check the official website link: https:// style="vertical-align: inherit;">For more forum information, please contact the P4 Organizing Committee:


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.